Skip to content

Investigation of Diabetic Foot Neuropathy using VIBRASENSE

A clinical investigation evaluating the risk of occurrence, presence and severity of Diabetic foot neuropathy using VIBRASENSE

Status
Active, not recruiting
Phases
Phase 3
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/11/047002
Enrollment
500
Registered
2022-11-03
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications

Interventions

None listed

Sponsors

CDSIMER
Lead Sponsor
DERBI foundation
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with Type 2 Diabetes militus of any duration confirmed by medical records with or without history of diagnosed - DPN 2. Patients who who are willing to participate as volunteers and sign the written informed consent

Exclusion criteria

Exclusion criteria: Patients with: 1. Active foot ulceration 2. Visual evidence of recently healed foot ulceration 3. Lowerlimb amputation of any kind 4. Diagnosed PN of any origin other than diabetes 5. Alcoholic neuropathy

Design outcomes

Primary

MeasureTime frame
Sense of vibrationTimepoint: One time

Secondary

MeasureTime frame
RBSTimepoint: One time

Countries

India

Contacts

Public ContactNishant Kathpal

College of Physiotherapy Dayananda Sagar University

srihari-physio@dsu.edu.in9886040520

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 10, 2026